Comparison of aflibercept and bevacizumab in the treatment of type 1 retinopathy of prematurity

BACKGROUND: To evaluate the outcome of intravitreal bevacizumab (IVB) and aflibercept (IVA) injection for patients with retinopathy of prematurity (ROP). METHODS: In this single-center retrospective cohort, the recorded medical data of the infants who had been undergone intravitreal injection with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Riazi-esfahani, Hamid, Mahmoudi, Alireza, Sanatkar, Mehdi, Farahani, Afsar Dastjani, Bazvand, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513371/
https://www.ncbi.nlm.nih.gov/pubmed/34645516
http://dx.doi.org/10.1186/s40942-021-00334-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513371/
https://www.ncbi.nlm.nih.gov/pubmed/34645516
http://dx.doi.org/10.1186/s40942-021-00334-4

Ejemplares similares